GC0000102A - Novel compositions comprising potentiators and chemotherapeutic agents. - Google Patents

Novel compositions comprising potentiators and chemotherapeutic agents.

Info

Publication number
GC0000102A
GC0000102A GCP1999159A GC0000102A GC 0000102 A GC0000102 A GC 0000102A GC P1999159 A GCP1999159 A GC P1999159A GC 0000102 A GC0000102 A GC 0000102A
Authority
GC
Cooperation Council for the Arab states of the Gulf
Prior art keywords
potentiators
chemotherapeutic agents
novel compositions
compositions
novel
Prior art date
Application number
Other languages
English (en)
Inventor
Randall K Johnson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22199389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GC0000102(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of GC0000102A publication Critical patent/GC0000102A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
GCP1999159 1998-05-21 1999-05-19 Novel compositions comprising potentiators and chemotherapeutic agents. GC0000102A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8656098P 1998-05-21 1998-05-21

Publications (1)

Publication Number Publication Date
GC0000102A true GC0000102A (en) 2005-06-29

Family

ID=22199389

Family Applications (1)

Application Number Title Priority Date Filing Date
GCP1999159 GC0000102A (en) 1998-05-21 1999-05-19 Novel compositions comprising potentiators and chemotherapeutic agents.

Country Status (28)

Country Link
US (1) US6582689B1 (xx)
EP (1) EP1079818B1 (xx)
JP (1) JP4283998B2 (xx)
KR (1) KR100624588B1 (xx)
CN (1) CN1227027C (xx)
AR (1) AR019844A1 (xx)
AT (1) ATE245440T1 (xx)
AU (1) AU750918B2 (xx)
BR (1) BR9910622A (xx)
CA (1) CA2328603A1 (xx)
CO (1) CO5050337A1 (xx)
CZ (1) CZ300496B6 (xx)
DE (1) DE69909781T2 (xx)
DK (1) DK1079818T3 (xx)
ES (1) ES2204164T3 (xx)
GC (1) GC0000102A (xx)
HK (1) HK1035136A1 (xx)
HU (1) HUP0600520A2 (xx)
IL (2) IL139733A0 (xx)
MY (1) MY123434A (xx)
NO (1) NO329195B1 (xx)
NZ (1) NZ508115A (xx)
PL (1) PL200840B1 (xx)
PT (1) PT1079818E (xx)
TR (1) TR200003453T2 (xx)
TW (1) TWI227136B (xx)
WO (1) WO1999059565A1 (xx)
ZA (1) ZA200006675B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002324249B2 (en) * 2001-03-08 2007-04-05 Ares Trading S.A. Interleukin-18 mutants, their production and use
US20050079153A1 (en) * 2002-08-14 2005-04-14 Pfizer Inc. Methods for enhancing immune functions in neonatal mammals by administration of IL-18
EP1572228A4 (en) * 2002-09-19 2009-03-04 Centocor Inc METHOD FOR INDUCING MATURATION OF DENDRITIC CELLS AND USES THEREOF
ES2322605T3 (es) * 2004-08-20 2009-06-23 Smithkline Beecham Corporation Tratamiento de la mucositis oral e intestinal mediante la administracion de il-18 humano.
EP2059253A4 (en) * 2006-09-14 2011-09-14 Univ Pennsylvania MODULATION OF REGULATORY T CELLS BY HUMAN IL-18
PE20090190A1 (es) * 2007-03-23 2009-03-22 Smithkline Beecham Corp Combinacion de anticuerpos anti-cd20 y polipeptidos de il-18
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
US8168165B2 (en) * 2008-12-23 2012-05-01 Abbott Laboratories Alkylated interleukin-18 compositions
TW201506402A (zh) * 2013-08-15 2015-02-16 Tonyar Biotech Inc 自體防潮的檢驗芯片及其製造方法
US20190070262A1 (en) * 2017-09-06 2019-03-07 Yale University Interleukin-18 variants and methods of use
IL302517A (en) 2020-11-02 2023-07-01 Simcha Il 18 Inc Variants of interleukin-18 and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
JP4004088B2 (ja) 1995-09-26 2007-11-07 株式会社林原生物化学研究所 免疫担当細胞においてインターフェロン−γの産生を誘導する蛋白質
TW581771B (en) 1994-11-15 2004-04-01 Hayashibara Biochem Lab Recombinant production of a polypeptide for inducing interferon-gamma production, and monoclonal antibody against the polypeptide
US6207641B1 (en) * 1995-03-10 2001-03-27 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Pharmaceutical composition containing IFN-γ inducing polypeptide or factor for treating and/or preventing IFN-γ susceptive diseases
US5869535A (en) * 1995-03-21 1999-02-09 The Board Of Trustees Of The University Of Illinois Method and composition for selectively inhibiting melanoma
JP4024366B2 (ja) 1996-11-29 2007-12-19 株式会社林原生物化学研究所 ポリペプチド

Also Published As

Publication number Publication date
CA2328603A1 (en) 1999-11-25
DE69909781T2 (de) 2004-05-27
NZ508115A (en) 2003-12-19
PL200840B1 (pl) 2009-02-27
AU750918B2 (en) 2002-08-01
PL366170A1 (en) 2005-01-24
ES2204164T3 (es) 2004-04-16
CZ300496B6 (cs) 2009-06-03
NO20005857D0 (no) 2000-11-20
CN1227027C (zh) 2005-11-16
CZ20004321A3 (en) 2001-05-16
JP2003509333A (ja) 2003-03-11
JP4283998B2 (ja) 2009-06-24
CO5050337A1 (es) 2001-06-27
PT1079818E (pt) 2004-02-27
EP1079818A1 (en) 2001-03-07
HUP0600520A2 (en) 2006-10-28
AR019844A1 (es) 2002-03-20
WO1999059565A1 (en) 1999-11-25
NO329195B1 (no) 2010-09-13
KR20010052369A (ko) 2001-06-25
IL139733A0 (en) 2002-02-10
TR200003453T2 (tr) 2001-10-22
TWI227136B (en) 2005-02-01
EP1079818A4 (en) 2001-12-12
KR100624588B1 (ko) 2006-09-18
ATE245440T1 (de) 2003-08-15
ZA200006675B (en) 2002-02-27
DE69909781D1 (de) 2003-08-28
MY123434A (en) 2006-05-31
EP1079818B1 (en) 2003-07-23
IL139733A (en) 2009-06-15
HK1035136A1 (en) 2001-11-16
AU4309499A (en) 1999-12-06
CN1367686A (zh) 2002-09-04
DK1079818T3 (da) 2004-04-19
NO20005857L (no) 2000-11-21
US6582689B1 (en) 2003-06-24
BR9910622A (pt) 2001-01-30

Similar Documents

Publication Publication Date Title
ZA991951B (en) Compound and its use.
GB2342193B (en) Addition circuitry
HK1037061A1 (en) Electrode material and compositions including same.
EP0989459A4 (en) CHEMICALLY AMPLIFIED PROTECTIVE AGENT COMPOSITION
IL128869A0 (en) Pyrozolopyrimidines and pyrazolotriazines
BG105437A (en) REFLECTIVELY MODIFIED COMPOSITIONS AND METHODS FOR OBTAINING THEM
GB9819530D0 (en) Novel compositions and use
EP1056456A4 (en) R-LANSOPRAZOL COMPOSITIONS AND TREATMENTS THEREFOR
GB9817235D0 (en) Compound,composition and use
PL348668A1 (en) 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
EP1056457A4 (en) S-LANSOPRAZOLE COMPOSITIONS AND METHODS OF USE
GC0000102A (en) Novel compositions comprising potentiators and chemotherapeutic agents.
GB9817236D0 (en) Compound,composition and use
PL339920A1 (en) Synergetic compositions comprising oxathiazine and benzothiophene-2-carboxamido-s,s-dioxide
GB9806788D0 (en) Composition
EP1073333A4 (en) S-RABEPRAZOL COMPOSITIONS AND METHODS
GB9903447D0 (en) Compound, composition and use
ZA991232B (en) New compound and pharmaceutical compositions thereof.
GB9817238D0 (en) Compound,composition and use
ZA991575B (en) N-sulphonyl and N-sulphinyl phenylglycinamide.
ZA200006118B (en) Novel composition.
ZA200000192B (en) Novel composition.
EP1073332A4 (en) R-RABEPRAZOL COMPOSITIONS AND METHODS
IL139961A0 (en) Composition based on pentoxifylline and anticytokin
GB2392159B (en) Endo-ß-1, 4, xylanase and uses thereof